Skip to main content

Anovulation

1
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
1
Gonal-FPhase 3
Roche
RocheSTAVANGER NORWAY, Norway
1 program
Orlistat Vs MetforminN/A
Genentech
GenentechCA - Oceanside
1 program
Orlistat Vs MetforminN/A1 trial
Active Trials
NCT00292799Completed36Est. Feb 2008
Qilu Pharmaceutical
Qilu PharmaceuticalChina - Jinan
1 program
Gonal-FPHASE_31 trial
Active Trials
NCT02335879Completed534
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
Highly Purified UrofollitropinPHASE_31 trial
Active Trials
NCT01923194Completed215Est. Aug 2015
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
MSJ-0011PHASE_31 trial
Active Trials
NCT01653743Completed81Est. Dec 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ferring PharmaceuticalsHighly Purified Urofollitropin
Merck & Co.MSJ-0011
Qilu PharmaceuticalGonal-F
GenentechOrlistat Vs Metformin

Clinical Trials (4)

Total enrollment: 866 patients across 4 trials

NCT01923194Ferring PharmaceuticalsHighly Purified Urofollitropin

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females

Start: Oct 2013Est. completion: Aug 2015215 patients
Phase 3Completed

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Start: Sep 2012Est. completion: Dec 201481 patients
Phase 3Completed

Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation

Start: May 2008534 patients
Phase 3Completed
NCT00292799GenentechOrlistat Vs Metformin

An RCT of Metformin Vs Orlistat in Obese Anovulatory Women

Start: Feb 2006Est. completion: Feb 200836 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.